---
schema_version: "secwatch.filing_event.v1"
accession: "0001100682-24-000004"
form_type: "8-K"
ticker: "CRL"
cik: "0001100682"
company_name: "CHARLES RIVER LABORATORIES INTERNATIONAL, INC."
filed_at: "2024-01-24T23:59:59+00:00"
generated_at: "2026-06-06T19:02:30.289360+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Charles River Labs appoints Reshema Kemps-Polanco to board; board expands to 12

## Summary
- Board increased from 11 to 12; Kemps-Polanco appointed effective Jan 22, 2024.
- She will serve on Compensation Committee and Strategic Planning and Capital Allocation Committee.
- Received initial pro-rata equity award valued at $255,500 in RSUs and stock options.
- Kemps-Polanco is EVP and Chief Commercial Officer of Novartis US with 25 years pharma experience.
- No material transactions or arrangements with Kemps-Polanco requiring disclosure.

## SEC filing metadata
- accession: 0001100682-24-000004
- form_type: 8-K
- ticker: CRL
- cik: 0001100682
- company_name: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- filed_at: 2024-01-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1100682/000110068224000004/0001100682-24-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1100682/000110068224000004/crl-20240122.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001100682-24-000004
- JSON: https://secwatch.observer/filing/0001100682-24-000004.json
- Plain text: https://secwatch.observer/filing/0001100682-24-000004.txt

## Key facts
- Executive change
  Reshema Kemps-Polanco was appointed as Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..
  - Action: appointed
  - Role: Director
  source text: Following the size increase of the Board, the Board filled the vacancy and appointed Ms. Reshema Kemps-Polanco to the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1100682/000110068224000004/0001100682-24-000004-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.